NCT01601912View on ClinicalTrials.gov

Unraveling the Nature of Impaired Pain Inhibition in Patients With Chronic Whiplash-associated Disorders

CompletedOBSERVATIONAL
Enrollment

59

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Whiplash Injuries
Interventions
DRUG

Atomoxetine

40 mg, 1 application

DRUG

Citalopram

20 mg, 1 application

Trial Locations (1)

1090

Universitair Ziekenhuis Brussel, Brussels

All Listed Sponsors
lead

Vrije Universiteit Brussel

OTHER

NCT01601912 - Unraveling the Nature of Impaired Pain Inhibition in Patients With Chronic Whiplash-associated Disorders | Biotech Hunter | Biotech Hunter